IDXX IDEXX Laboratories, Inc. logo

IDXX IDEXX Laboratories, Inc.

Healthcare
$559.37+1.14%ClosedMarket Cap: $44.12B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

42.31

PEG

2.19

P/B

28.79

P/S

9.92

EV/EBITDA

29.60

DCF Value

$174.76

FCF Yield

2.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

62.1%

Operating Margin

31.6%

Net Margin

24.6%

ROE

70.9%

ROA

32.4%

ROIC

40.7%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$1.14B$278.4M$
Q4 null$1.09B$248.2M$
FY null$4.30B$1.06B$
Q3 null$1.11B$274.6M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$747.50

Target (Median)

$775.00

Target Range

$640.00 - $800.00

4 Strong Buy5 Buy5 Hold0 Sell1 Strong Sell
UBSNeutral
2026-04-28
StifelBuy
2026-03-31
Piper SandlerNeutral
2026-02-09
BarclaysOverweight
2026-02-05
UBSNeutral
2026-02-03

Trading Activity

Insider Trades

View All
Vandebroek Sophie V.director
SellThu May 14
Vandebroek Sophie V.director
SellThu May 14
SAMAD SAMdirector
SellThu May 14
SAMAD SAMdirector
SellThu May 14
Peacock Karendirector
SellThu May 14

Congress Trades

View All
Ro KhannaBuy
Wed May 13

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

Beta

1.57

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Peers